CellVoyant
PrivateLast Round
Seed
Jan 15, 2024
Total Funding Raised
$12.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellVoyant is a biotechnology company that utilizes AI-first live-cell imaging to predict and optimize stem cell differentiation for the development of novel cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, ML Platforms, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellVoyant Comparables
Compare CellVoyant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autolomous | 66% | |
| Sartorius Aktiengesellschaft | 64% | |
| Danaher Corporation | 60% | |
CellVoyant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 15, 2024 | ||||
| Pre Seed | Dec 1, 2021 |
Key People
Founding team and executive leadership
CellVoyant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed |
| Verve Ventures | Seed |
| Air Street Capital | Seed |
| Octopus Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 19, 106% of headcount.
- Jan 13, 2026
Integrated AI foundation models with Automata's LINQ platform for adaptive cell culture.
CellVoyant Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellVoyant's valuation, stock price, and market status.